MALIGNANT MELANOMA

Most people have heard of malignant melanoma and know it is a serious cancer of the skin. The cells involved are the melanocytes, the cells of the skin that produce the pigment known as melanin. In humans, malignant melanoma is associated with sun-exposure and sunburn damage and is an important reason for one's skin surface to be regularly scanned for pigmented growths. The situation in pets similarly involves serious cancer of the melanocytes and often pigmented growths but in pets specific body parts are classically involved and while any pigmented growth should be reported to the vet, there are specific areas on the body to be particularly concerned about and sun exposure is not as important.

The melanoma is a tumor of pigmented cells called “melanocytes.”

BENIGN VERSUS MALIGNANT MELANOMAS/HAIRED SKIN MELANOMAS

It turns out that the behavior of a melanoma is highly dependent on the region of the body where it develops. Most areas of skin grow benign versions of the melanoma which are called, “melanocytomas.” This means that a pigmented growth found on haired skin in an area that is not considered a "danger zone" is likely to behave benignly. That said, they do not all behave benignly, it is important to have all tumors analyzed by a pathologist so that a given tumor's behavior can be predicted. What ancillary treatment or testing is recommended (if any) will be determined based on this tissue analysis.

Many melanomas removed from haired skin show cells that look malignant under the microscope but do not behave in a malignant manner. To get a better sense of how a given tumor will behave, the number of cells in the process of division are counted in the sample. This is reflected by a number called the "mitotic index" of the tumor and is expressed as the number of "mitotic figures" (cells in the process of dividing) per high power field (microscopic view). Less than 3 mitotic figures per high power field indicates the tumor will mostly likely behave in a benign manner. There is evidence that staining the sample for special tissue markers (such as "Ki-67") can help predict behavior as well.

There is some suspicion that haired skin melanomas developing within 1 cm of a mucosal margin (like the mouth or genital area) behave more malignantly than one would expect based on what is seen under the microscope. Always have growths biopsied after removal and do not be shy about consulting an oncology specialist if there is any question.

Let us return to the concept of the "danger zones." There are several areas that grow particularly invasive melanomas, which are not only locally destructive but spread cancer to the lung, liver and other areas. The areas where melanoma development is particularly threatening include:

• Mouth/Lips/Oral Cavity
• Toe/Foot
• Eye

Each of these areas produces a somewhat different syndrome and we will review each separately.

ORAL MELANOMA

• Stage I: approximately 17-18 months (with surgery alone)
• Stage II: approximately 6 months (with surgery alone)
• Stage III: approximately 3 months (with surgery alone)
• Stage IV: approximately 1 month (surgery not applicable)

The goal additional adjunctive therapy (radiation, chemotherapy, immunotherapy) is to extend this time.

LOCAL DISEASE CONTROL
Local disease control refers to control of the disease in the mouth. Ideally most of the tumor can be surgically removed; however, even an extensive resection is not likely to remove the entire tumor with certainty and some kind of adjunctive treatment will be prudent. Radiation in the area has extended the time until the tumor regrows in areas where complete margins cannot be obtained (i.e. biopsy shows there is still more tumor left). If margins are clean, immunotherapy (see later) may be all that is recommended.

DISTANT DISEASE CONTROL
If there is documentation that the tumor has escaped and colonized another site in the body (i.e. the patient is in Stage IV), more extensive treatment is needed and this usually means chemotherapy. The melanoma is notoriously not very responsive to chemotherapy in people but research and new drug development continues. In one study carboplatin combined with piroxicam increased median survival time from 30 days to 119 days in Stage IV patients.

MICROSCOPIC DISEASE
After no disease is detectable to the eye, we cannot be sure about undetectable disease: malignant cells in transit, looking for a place to set up shop. Chemotherapy helps reach these cells as does immunotherapy, a newer mode of cancer treatment. Immunotherapy involves generating an immune-response against the tumor cells and attacking them with the body's own natural system. Periodic screening tests/staging are needed to see if the tumor has succeeded in settling in a distant organ and therapy can be ramped up to address this event.

MELANOMA IN THE EYE

The pigments of the iris and ciliary body within the eye are especially vulnerable to melanoma development. These tumors are particularly difficult to see until they are fairly large. The clinical situation is very different depending on if the patient is a cat or a dog.

Uveal/Iris Melanoma - Dogs
The good news is that this is a benign condition in at least 80% of patients. The bad news is that an expanding growth inside the eye, even a benign growth, can cause pain and blindness. If glaucoma (increased eye pressure) has resulted or if there is deep inflammation in the eye, rapid tumor growth, or vision loss, it is probably worth simply removing the eye (enucleation) though smaller growths might be amenable to laser therapy.

Uveal/Iris Melanoma - Cat
The feline situation is very different in that 60-70% of these tumors are malignant and will spread. Tumors can be large and bulgy as in the dog eye or they can be more subtle, starting as flat areas of pigment on the iris (colored part of the eye) and later gaining some 3-dimensional growth. The eye will likely need removal to manage the pain from the expanding growth but it is important to do proper staging first (radiographs of the chest, local lymph node sampling, ultrasound of the abdominal organs) to determine the extent of the existing tumor spread.

Iris melanosis, which is a benign condition, can be impossible to distinguish from an early melanoma so often periodic evaluation by a specialist is in order. Iris melanosis refers to the "freckles" and flat dark spots that older cats develop on their irises. These spots are common but should not have any bulging or changing roughness when the iris is viewed from the side. Epibulbar Melanoma This form of melanoma is usually benign in either dogs or cats and arises on the outer eye portion where the sclera (white part) meets the cornea (clear part over the iris). Smaller growths may not need treatment. Larger ones can be surgically removed, treated with laser or with cryosurgery. Tumor spread is not expected with this form of melanoma.

Example of iris melanosis: a benign condition (not melanoma) (original graphic by marvistavet.com)

MELANOMA TREATMENT

As mentioned, treatment is divided into local disease control, distant disease control, and microscopic disease control. Surgery and radiotherapy are the fundamental treatments for local disease whereas chemotherapy is the foundation of distant disease control. Different medications and protocols are being developed all the time. Immunotherapy is a little harder to classify.

THE MELANOMA VACCINE

A melanoma vaccine has been in use for nearly a decade now, not to prevent melanoma development but to generate an active immune response against an existing tumor. The vaccine was tested on dogs with Stage II and Stage III oral melanoma after all detectable tumor was surgically removed with improved survival times achieved over what was expected from surgery alone. The vaccine has also been found helpful for toe/digit melanomas as well.

The vaccine is for dogs without grossly detectable tumor; it will probably not be helpful for dogs where there is already distant tumor spread.

How it works

An enzyme called “tyrosinase” is crucial to the melanocyte’s ability to produce melanin (pigment). By using human tyrosinase as a stimulator, the patient’s immune system can be tricked into attacking the melanoma cells which contain the patient’s natural tyrosinase. The vaccine is available only through veterinary oncology specialists. It is given in four single doses at 2 week intervals. Booster shots are given every 6 months and is best used for dogs with oral melanoma without node involvement. Life expectancy has been extended to over one year in many cases.

For more information on the new melanoma vaccine and about canine melanoma in general, visit:

bi-animalhealth.com/pets/canine/products/therapeutics/oncept

TO LOCATE A VETERINARY ONCOLOGIST

http://vetcancersociety.org/pet-owners/find-a-vcs-member(if link does not work, copy and paste this URL into your browser)

Page posted: 4/20/09
Page last updated: 7/1/2024